Oral Session 1-14A Immune Cell Therapy Using iPS Cells

[OS1-14A-5] Development of iPS cell derived LMP1-CART therapy for refractory EB virus associated lymphomas

Sakiko Harada¹, Miki Ando^1,2, Jun Ando¹, Satoshi Yamasaki², Midori Ishii¹, Tadahiro Honda¹, Kazuo Ohara¹, Yumi Sakiyama¹, Yozo Nakazawa³, Malcolm K. Brenner⁴, Hiromitsu Nakauchi^2,5, Norio Komatsu¹ (1.Department of Hematology, Juntendo University School of Medicine, 2.Division of Stem Cell Therapy, IMSUT, Tokyo, 3.Department of Pediatrics, Shinshu University School of Medicine, 4.CAGT, Baylor College of Medicine, TX, USA, 5.Institute for Stem Cell Biology and Regenerative Medicine, Stanford University)